3ccn

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:3ccn.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:3ccn.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_3ccn| PDB=3ccn | SCENE= }}
{{STRUCTURE_3ccn| PDB=3ccn | SCENE= }}
-
'''X-ray structure of c-Met with triazolopyridazine inhibitor.'''
+
===X-ray structure of c-Met with triazolopyridazine inhibitor.===
-
==Overview==
+
<!--
-
Tumorigenesis is a multistep process in which oncogenes play a key role in tumor formation, growth, and maintenance. MET was discovered as an oncogene that is activated by its ligand, hepatocyte growth factor. Deregulated signaling in the c-Met pathway has been observed in multiple tumor types. Herein we report the discovery of potent and selective triazolopyridazine small molecules that inhibit c-Met activity.
+
The line below this paragraph, {{ABSTRACT_PUBMED_18426196}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 18426196 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_18426196}}
==Disease==
==Disease==
Line 43: Line 47:
[[Category: Transmembrane]]
[[Category: Transmembrane]]
[[Category: Tyrosine-protein kinase]]
[[Category: Tyrosine-protein kinase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed May 28 09:37:59 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 08:55:38 2008''

Revision as of 05:55, 29 July 2008

Image:3ccn.png

Template:STRUCTURE 3ccn

Contents

X-ray structure of c-Met with triazolopyridazine inhibitor.

Template:ABSTRACT PUBMED 18426196

Disease

Known disease associated with this structure: Hepatocellular carcinoma, childhood type OMIM:[164860], Renal cell carcinoma, papillary, familial and sporadic OMIM:[164860], Autism, suseptibility to, 9 OMIM:[164860]

About this Structure

3CCN is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase., Albrecht BK, Harmange JC, Bauer D, Berry L, Bode C, Boezio AA, Chen A, Choquette D, Dussault I, Fridrich C, Hirai S, Hoffman D, Larrow JF, Kaplan-Lefko P, Lin J, Lohman J, Long AM, Moriguchi J, O'Connor A, Potashman MH, Reese M, Rex K, Siegmund A, Shah K, Shimanovich R, Springer SK, Teffera Y, Yang Y, Zhang Y, Bellon SF, J Med Chem. 2008 May 22;51(10):2879-82. Epub 2008 Apr 22. PMID:18426196

Page seeded by OCA on Tue Jul 29 08:55:38 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/3ccn"
Personal tools